Home/Filings/4/0001127602-23-004928
4//SEC Filing

Granowitz Craig B 4

Accession 0001127602-23-004928

CIK 0001062822other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 4:59 PM ET

Size

7.7 KB

Accession

0001127602-23-004928

Insider Transaction Report

Form 4
Period: 2023-02-09
Granowitz Craig B
SVP, Chief Medical Officer
Transactions
  • Award

    Restricted Stock Units

    2023-02-09+107,370107,370 total
    Common Stock (107,370 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-02-09+322,110322,110 total
    Exercise: $2.43Exp: 2033-02-09Common Stock (322,110 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
  • [F3]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

Entity typeother

Related Parties

1
  • filerCIK 0001876655

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:59 PM ET
Size
7.7 KB